Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

1.2K
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
1.2K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

7.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.0K
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

80
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
80
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

11.9K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.9K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

4.3K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.3K
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

40
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
40

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LMSCDA: A Secondary Structure Enhanced Language Model for Predicting CircRNA and Disease Associations.

IEEE journal of biomedical and health informatics·2026
Same author

Integrating Transformer and Graph Attention Network for circRNA-miRNA Interaction Prediction.

IEEE journal of biomedical and health informatics·2025
Same author

A heterogeneous information network learning model with neighborhood-level structural representation for predicting lncRNA-miRNA interactions.

Computational and structural biotechnology journal·2025
Same author

Motif-Aware miRNA-Disease Association Prediction via Hierarchical Attention Network.

IEEE journal of biomedical and health informatics·2024
Same author

Biolinguistic graph fusion model for circRNA-miRNA association prediction.

Briefings in bioinformatics·2024
Same author

Likelihood-based feature representation learning combined with neighborhood information for predicting circRNA-miRNA associations.

Briefings in bioinformatics·2024

Related Experiment Video

Updated: Feb 26, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.7K

Multi-relational knowledge graph for drug-drug interaction prediction via dual aggregation and collaborative

Yu Wei1, Meng-Meng Wei2, Bo-Wei Zhao3

  • 1Guangxi Key Lab of Human-machine Interaction and Intelligent Decision, Guangxi Academy of Sciences, Nanning 530007, China; School of Computer Science, Northwestern Polytechnical University, Xi'an 710129, China.

Bioorganic Chemistry
|February 24, 2026
PubMed
Summary

A new framework, MRACO, improves drug-drug interaction (DDI) prediction by efficiently handling complex data in knowledge graphs. This method enhances understanding of drug interactions for safer clinical use and development.

Keywords:
Deep learningDrug-drug interactionsHigh-order neighborhood informationLink predictionRelational graph convolutional network

More Related Videos

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.2K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.7K

Related Experiment Videos

Last Updated: Feb 26, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.7K
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.2K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.7K

Area of Science:

  • Computational chemistry
  • Pharmacology
  • Bioinformatics

Background:

  • Drug-drug interactions (DDIs) are critical in clinical practice and drug development, posing risks of adverse reactions.
  • Computational methods are increasingly used for DDI prediction but face challenges with complexity and heterogeneous information.
  • Existing models often struggle with node feature representation and capturing entity interactivity and polysemy.

Purpose of the Study:

  • To propose a novel framework, MRACO (Multi-Relational dual Aggregation and Collaborative Optimization), for accurate DDI prediction.
  • To address limitations of existing computational methods in handling complex, heterogeneous information within knowledge graphs.
  • To enhance the efficiency and robustness of DDI prediction models.

Main Methods:

  • Developed a dual aggregation and collaborative optimization learning framework (MRACO) utilizing multi-relational knowledge graphs.
  • Employed dual aggregation operations to encode and aggregate multi-type information, capturing diverse semantic relationships of drug nodes.
  • Utilized a collaborative loss optimization function to simplify computations, reduce redundancy, and improve model robustness.

Main Results:

  • MRACO effectively utilizes structural information from multi-relational knowledge graphs to learn interactivity across relationship types.
  • The framework demonstrates strong feature extraction capabilities in multi-relational networks.
  • Experiments confirm MRACO's enhanced understanding of the underlying mechanisms of DDIs, leading to improved prediction stability.

Conclusions:

  • MRACO offers an effective solution for DDI prediction by leveraging knowledge graph structures and advanced learning techniques.
  • The proposed framework overcomes computational complexity and information heterogeneity challenges in current DDI prediction models.
  • MRACO's ability to integrate deep-level interactive information enhances prediction accuracy and stability, contributing to safer drug development and clinical application.